Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Zolbetuximab (e.g., Vyloy) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ziv-aflibercept (e.g., Zaltrap) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Zenocutuzumab-zbco (e.g., Bizengri) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Zanidatamab-hrii (e.g., Ziihera) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus and Colon | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Outdoor Behavioral Health Therapy-Wilderness Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Whole Body Computed Tomography Scan as a Screening Test | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | White Blood Cell Growth Factors (Colony Stimulating Factors) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Viscocanalostomy and Canaloplasty | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Virtual Colonoscopy/CT Colonography | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Vestibular Function Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Vertical Expandable Prosthetic Titanium Rib | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Minimally Invasive Approaches to Vertebral Fractures and Osteolytic Lesions of the Spine (Vertebroplasty, Sacroplasty, Kyphoplasty, and Mechanical Vertebral Augmentation) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ventricular Assist Devices | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Velmanase alfa-tycv (e.g., Lamzede) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Vedolizumab (e.g., Entyvio) for Inflammatory Bowel Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Valoctocogene roxaparvovec-rvox (e.g., Roctavian) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Vagus Nerve Stimulation | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Vacuum Assisted Closure Device | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Uterus Transplantation for Absolute Uterine Factor Infertility | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ustekinumab (e.g., Stelara) and Biosimilars | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ultrasound Treatment for Wounds, Non-Contact | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ultrasound in Maternity Care: 1st Trimester Detection of Down Syndrome using Fetal US Assessment of Nuchal Translucency & Maternal Serum Assessment | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ultrasound in Maternity Care | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Low Intensity Pulsed Ultrasound Fracture Healing Device | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ublituximab-xiiy (e.g., Briumvi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tumor-Treating Fields Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tumor-informed Circulating Tumor DNA Testing (e.g., Signatera) for Cancer Management | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tumor Markers, Urinary Bladder Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tumor Antigen, Prostate Specific Antigen (PSA) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tumor Antigen, CA 125 (Carcinoembryonic Antigen 125) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Triptorelin (e.g., Triptodur, Trelstar) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Trilaciclib (e.g., Cosela) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Triamcinolone Acetonide Extended Release (e.g., Zilretta) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treosulfan (e.g., Grafapex) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Tremelimumab-actl (e.g., Imjudo) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatments for Duchenne Muscular Dystrophy (eg. Eteplirsen, Golodirsen, Viltolarsen, and Casimersen) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatment of Varicose Veins/Venous Insufficiency | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatment of Sacroiliac Joint (SIJ) Pain | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatment of Hereditary Transthyretin-mediated Amyloidosis [Patisiran (e.g., Onpattro) and Vutrisiran (e.g., Amvuttra)] | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Treatment for Gaucher Disease: [Imiglucerase (e.g., Cerezyme), taliglucerase alfa (e.g., Elelyso), and velaglucerase alfa (e.g., Vpriv)] | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Travoprost Intracameral implant (iDose TR) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Trastuzumab (e.g., Herceptin) and Biosimilars and Trastuzumab/Hyaluronidase-oysk (e.g., Herceptin Hylecta) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Small Bowel/Liver and Multivisceral | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Small Bowel | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Lung and Lobar Lung | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Liver | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Kidney | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Transplant, Heart/Lung | New policy |